A 12-week dual-task training program significantly improved cognitive function (MoCA score increased by 28.4%, p=0.001) compared to control in patients with mild Alzheimer's disease.
RCT (n=26)
Single-blind
Block randomization
No
Does 12 weeks of dual-task training improve cognitive status, physical performance, and brain oscillation in patients with Alzheimer's disease?
A 12-week dual-task training program significantly improves cognitive function, physical performance, and brain oscillation ratios in patients with mild Alzheimer's disease.
Standardized Mean Difference: 1.7
Absolute Event Rate: 23.9% vs 17.9%
p-value: p=0.001
This study aimed to investigate the effect of 12 weeks of dual-task training on cognitive status, physical performance, and brain oscillation of patients with Alzheimer’s disease (AD). Twenty-six AD patients were randomly assigned to two groups, the training group (TG) and control group (CG). TG executed progressive combined exercises with visual stimulation twice a week for 12 weeks. Training included muscle endurance, balance, flexibility, and aerobic exercises with eyes closed and opened. Brain oscillation on electroencephalography (EEG) and a series of physical, cognitive, and mental tests were taken before and post-intervention. There was a significant improvement after training protocol in cognitive function, particularly in short-term and working memory, attention, and executive function ( p 0.01). Besides, there were substantial improvements in depression status (GDS scale), aerobic fitness (6 min walking), flexibility (chair sit and reach) functional ability (chair stand, timed up and go test), strength (knee extensions, preacher biceps curl, handgrip) in TG compared to CG. These signs of progress were associated with a significant increase ( p 0.05) in the frequency of brain oscillation and a decrease in the theta/alpha ratio. In addition to physical performance, the regular combined training with visual stimulation improves brain health as indicated by improving cognitive function and reducing the theta/alpha ratio. Clinical Trial Registration: Iranian Registry of Clinical Trials (IRCT) https://www.irct.ir/ , identifier IRCT20190504043468N1—August 5, 2020.
Parvin et al. (Tue,) conducted a rct in Alzheimer's disease (n=26). Dual-task training vs. Control was evaluated on Montreal Cognitive Assessment (MoCA) score (Cohen's d 1.7, p=0.001). A 12-week dual-task training program significantly improved cognitive function (MoCA score increased by 28.4%, p=0.001) compared to control in patients with mild Alzheimer's disease.